Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	253.19	222.28	269.57	300.61	195.25	148.63
Cash & Short-Term Investments	253.19	222.28	269.57	300.61	195.25	148.63
Cash Growth	28.65%	-17.54%	-10.33%	53.96%	31.37%	46.83%
Accounts Receivable	109.25	194.67	248.37	301.49	379.88	357.93
Other Receivables	15.35	13	9	10.86	16.13	9.67
Receivables	124.59	207.67	257.37	312.34	396.01	367.6
Inventory	785.12	969	1,211	819.95	753.85	481.24
Prepaid Expenses	8.19	42.28	49.82	16.08	11.97	4.13
Total Current Assets	1,171	1,441	1,788	1,449	1,357	1,002
Property, Plant & Equipment	2,095	2,199	2,292	1,964	1,868	1,542
Long-Term Investments	1,025	1,002	994.48	998.25	1,060	543.89
Other Intangible Assets	2.04	3.77	5.56	7.53	1.8	1.29
Long-Term Deferred Tax Assets	65.73	35.55	20.44	20.14	24.48	16.76
Other Long-Term Assets	80.2	80.91	71.27	125.42	69.35	41.24
Total Assets	4,439	4,763	5,172	4,564	4,381	3,147
Accounts Payable	21.14	41.44	104.36	144.33	78.77	97.71
Accrued Expenses	44.45	57.75	122.22	193.56	143.72	140.91
Short-Term Debt	200	150	500	100	150	-
Current Portion of Leases	2.53	2.91	3.36	2.54	1.32	2.25
Current Income Taxes Payable	0.6	1.82	10.59	49.98	31.05	106.54
Current Unearned Revenue	46.54	124.31	15.91	53.95	73.99	3.66
Other Current Liabilities	35.38	47.06	74.97	69.83	156.34	49.09
Total Current Liabilities	350.64	425.29	831.41	614.18	635.17	400.16
Long-Term Debt	600	700	700	500	600	-
Long-Term Leases	3.28	3.98	4.47	0.72	1.02	0.82
Long-Term Unearned Revenue	6.26	12.74	27	-	-	-
Long-Term Deferred Tax Liabilities	264.92	263.79	258.54	256.22	250.3	247.5
Total Liabilities	1,225	1,406	1,821	1,371	1,486	648.48
Common Stock	769.18	775.6	775.6	775.6	775.6	775.6
Additional Paid-In Capital	331.76	334.53	334.53	334.32	334.32	334.32
Retained Earnings	2,176	2,312	2,296	2,129	1,744	1,385
Comprehensive Income & Other	-63.75	-65.17	-55.48	-46.05	39.76	3.72
Total Common Equity	3,214	3,357	3,350	3,193	2,894	2,498
Minority Interest	-	-	-	0.19	0.19	0.26
Shareholders' Equity	3,214	3,357	3,350	3,193	2,894	2,499
Total Liabilities & Equity	4,439	4,763	5,172	4,564	4,381	3,147
Total Debt	805.81	856.89	1,208	603.26	752.34	3.07
Net Cash (Debt)	-552.63	-634.61	-938.26	-302.65	-557.09	145.55
Net Cash Per Share	-14.02	-11.27	-12.01	-3.86	-7.11	1.86
Filing Date Shares Outstanding	76.92	77.56	77.56	77.56	77.56	77.56
Total Common Shares Outstanding	76.92	77.56	77.56	77.56	77.56	77.56
Working Capital	820.46	1,016	956.37	834.81	721.91	601.44
Book Value Per Share	41.78	43.28	43.20	41.17	37.31	32.21
Tangible Book Value	3,212	3,353	3,345	3,185	2,892	2,497
Tangible Book Value Per Share	41.75	43.23	43.12	41.07	37.29	32.20
Land	1,092	1,092	1,092	741.4	741.4	741.4
Buildings	950.02	948.27	936.09	900.62	826.11	674.26
Machinery	2,476	2,456	2,389	2,296	2,032	1,761
Construction In Progress	55.27	59.46	48.39	27.85	126.44	112.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.